Patent Assignment
Reel/Frame 046633/0753
Assignment of Assignor's Interest
Recorded: 2018-07-25
Pages: 13
Assignor
XENOPORT, INC.
Executed: 2018-04-20
Assignee
ARBOR PHARMACEUTICALS, LLC
6 CONCOURSE PARKWAY, SUITE 1800, ATLANTA, GEORGIA, 30328
Covered Properties
(75)
Methods for Synthesis of Prodrugs from 1-Acyl-Alkyl Derivatives and Compositions Thereof
Orally Administered Dosage Forms of Gaba Analog Prodrugs Having Reduced Toxicity
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Methods for Synthesis of Acyloxyalkyl Derivatives of Gaba Analogs
Amino Acid Derived Prodrugs of Propofol, Compositions and Uses Thereof
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Crystalline Form of Y-Aminobutyric Acid Analog
Treating or Preventing Restless Legs Syndrome Using Prodrugs of Gaba Analogs
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
LAT1 Transporters Expressed in Blood Brain Barrier Cells
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Methods for Synthesis of Prodrugs from 1-Acyl-Alkyl Derivatives and Compositions Thereof
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Platinum-Containing Compounds Exhibiting Cytostatic Activity, Synthesis and Methods of Use
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Methods for Synthesis of Acyloxyalkyl Derivatives of Gaba Analogs
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Sustained Release Oral Dosage Forms of a Prodrug of R-Baclofen and Methods of Treatment
Application:
11/972,575 →
Publication:
US 2008/0206332
Crystalline Form of a (3S)-Aminomethyl-5-Methyl-Hexanoic Acid Prodrug and Methods of Use
Mesophasic Forms of (3S)-Aminomethyl-5-Methyl-Hexanoic Acid Prodrugs and Methods of Use
Enantiomerically Resolving Acyloxyalkyl Thiocarbonates Used in Synthesizing Acyloxyalkyl Carbamate Prodrugs
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Methods for Synthesis of Prodrugs from 1-Acyl-Alkyl Derivatives and Compositions Thereof
Methods of Synthesizing N-Hydroxysuccinimidyl Carbonates
Methods of Synthesizing 1-(Acyloxy)-Alkyl Carbamate Prodrugs
Methods for Synthesis of Acyloxyalkyl Compounds
Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use
Methods of Synthesizing a Levodopa Ester Prodrug
Sustained Release Oral Dosage Forms of an R-Baclofen Prodrug
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Application:
12/883,860 →
Publication:
US 2011/0021571
Catechol Protected Levodopa Diester Prodrugs, Compositions, and Methods of Use
Pharmaceutical Compositions and Oral Dosage Forms of a Levodopa Prodrug and Methods of Use
Crystalline Form of a (3S)-Aminomethyl-5-Methyl-Hexanoic Acid Prodrug and Methods of Use
Use of (3R)-4-{[(1S)-2-Methyl-1-(2-Methylpropanoyloxy)Propoxy]Carbonylamino}-3-(4-Chlorophenyl) Butanoic Acid for Treating Urinary Incontinence
CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Methods of Using Prodrugs of Pregabalin
Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use
Methods of Using Prodrugs of Methyl Hydrogen Fumarate and Pharmaceutical Compositions Thereof
Anhydrous and Hemihydrate Crystalline Forms of an (R)-Baclofen Prodrug, Methods of Synthesis and Methods of Use
Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof
Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
Application:
13/906,155 →
Publication:
US 2013/0324539
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug
Application:
13/973,542 →
Publication:
US 2014/0056973
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Application:
13/973,622 →
Publication:
US 2014/0056978
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
Anhydrous and Hemihydrate Crystalline Forms of an (R)-Baclofen Prodrug, Methods of Synthesis and Methods of Use
CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
Pharmaceutical Compositions of Dimethyl Fumarate
Methods of Using Prodrugs of Methyl Hydrogen Fumarate and Pharmaceutical Compositions Thereof
Method of Making Monomethyl Fumarate
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Cocrystals of Dimethyl Fumarate
Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
Application:
14/449,513 →
Publication:
US 2015/0038499
Crystalline Forms of (N,N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Methods of Administering Monomethyl Fumarate
Application:
14/661,698 →
Publication:
US 2015/0190360
Pharmaceutical Compositions of Fumaric Acid Esters
Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
Application:
14/717,639 →
Publication:
US 2015/0252013
Prodrugs of Gaba Analogs, Compositions and Uses Thereof
Anhydrous and Hemihydrate Crystalline Forms of an (R)-Baclofen Prodrug, Methods of Synthesis and Methods of Use
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
Methods of Synthesizing a Levodopa Ester Prodrug
Crystalline Forms of (N,N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Oral Dosage forms having a High Loading of a Gabapentin Prodrug
Application:
15/294,457 →
Publication:
US 2017/0035714
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
Application:
15/457,191 →
Publication:
US 2017/0183296
Crystalline Forms of (N, N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Crystalline Forms of (N, N-Diethylcarbamoyl)Methyl Methyl (2E)but-2-Ene-1,4-Dioate, Methods of Synthesis and Use
Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis and Use
Gaba Analog Prodrug Sustained Release Oral Dosage Forms
Application:
15/925,013 →
Publication:
US 2018/0207117
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2015
From: GALLOP, MARK A.; CUNDY, KENNETH C.; ZHOU, CINDY X.; YAO, FENMEI
To: XENOPORT, INC.
Reel/Frame 035788/0560 →
Security Interest
Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
Assignment of Assignor's Interest
Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
Security Interest
Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
Release of Security Interest
Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents
Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →